Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer
CONCLUSIONS: We demonstrate that LOR stimulates fibrosis and inflammatory signaling, promotes desmoplasia and ischemic necrosis, and is associated with decreased pancreatic cancer patient survival.PMID:37587561 | DOI:10.1158/1078-0432.CCR-23-0547
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Abigail C Cornwell Arwen A Tisdale Swati Venkat Kathryn E Maraszek Abdulrahman A Alahmari Anthony George Kristopher Attwood Madison George Donald Rempinski Janusz Franco-Barraza Mukund Seshadri Mark D Parker Eduardo Cortes Gomez Christos Fountzilas Edna C Source Type: research
More News: Alprazolam | Ativan | Cancer | Cancer & Oncology | Chemotherapy | Lorazepam | Pancreas | Pancreatic Cancer | Xanax